Hu Szu-Yen, Chou Heng-Wen, Chen Yih-Sharng, Huang Shu-Chien
Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Acta Cardiol Sin. 2023 Mar;39(2):254-265. doi: 10.6515/ACS.202303_39(2).20220826B.
Total anomalous pulmonary venous connection (TAPVC) is a fatal congenital cardiac anomaly that requires urgent surgical intervention. The development of postoperative pulmonary vein obstruction (PVO) negatively impacts long-term survival.
The present study aimed to evaluate the surgical outcomes of TAPVC repair and risk factors associated with postoperative PVO.
Patients who underwent primary TAPVC repair at our institute between 2004 and 2022 were retrospectively enrolled, and those with right atrial isomerism and single ventricle physiology were excluded. Factors associated with survival and postoperative PVO were analyzed.
A total of 116 patients were enrolled in the present study. The early mortality rate was 6.9%. Nineteen patients (16.4%) developed postoperative PVO within a median time of 59 days of the primary repair, of whom 10 were successfully relieved without any recurrent obstruction. In long-term follow-up, patients with postoperative PVO had significantly lower long-term survival rates than those without postoperative PVO [57.9%, 95% confidence interval (CI) = 34.8-79.5%; vs. 90.4%, 95% CI = 83-96.6% at 10 years, p < 0.001]. Risk factors for postoperative PVO development included lower body weight, younger age, preoperative mechanical ventilation, preoperative inotrope use, and emergency operation.
Postoperative PVO was significantly associated with a higher long-term mortality rate after primary TAPVC repair, with the risk being higher in patients with critical preoperative status. The long-term outcome was good for patients in whom the obstruction was successfully relieved. Early detection and prompt intervention for postoperative PVO after TAPVC repair can improve overall survival in these patients.
完全性肺静脉异位连接(TAPVC)是一种致命的先天性心脏畸形,需要紧急手术干预。术后肺静脉梗阻(PVO)的发生对长期生存产生负面影响。
本研究旨在评估TAPVC修复的手术结果以及与术后PVO相关的危险因素。
回顾性纳入2004年至2022年在我院接受初次TAPVC修复的患者,排除右心房异构和单心室生理状态的患者。分析与生存及术后PVO相关的因素。
本研究共纳入116例患者。早期死亡率为6.9%。19例患者(16.4%)在初次修复后的中位时间59天内发生术后PVO,其中10例成功缓解且无任何复发梗阻。在长期随访中,术后发生PVO的患者长期生存率显著低于未发生术后PVO的患者[57.9%,95%置信区间(CI)=34.8 - 79.5%;10年时分别与90.4%,95%CI = 83 - 96.6%相比,p < 0.001]。术后PVO发生的危险因素包括体重较低、年龄较小、术前机械通气、术前使用血管活性药物以及急诊手术。
术后PVO与初次TAPVC修复后较高的长期死亡率显著相关,术前病情危急的患者风险更高。梗阻成功缓解的患者长期预后良好。TAPVC修复术后对PVO进行早期检测和及时干预可提高这些患者的总体生存率。